Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Gastric Cancer

  Free Subscription


Articles published in J Cancer Res Clin Oncol

Retrieve available abstracts of 37 articles:
HTML format
Text format



Single Articles


    February 2018
  1. YE J, Huang Q, Xu J, Huang J, et al
    Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth.
    J Cancer Res Clin Oncol. 2018 Feb 12. pii: 10.1007/s00432-018-2605.
    PubMed     Text format     Abstract available


    December 2017
  2. LI S, Lan X, Gao H, Li Z, et al
    Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection.
    J Cancer Res Clin Oncol. 2017;143:2455-2468.
    PubMed     Text format     Abstract available


    April 2017
  3. ZHANG S, Shang Y, Chen T, Zhou X, et al
    Human circulating and tissue gastric cancer stem cells display distinct epithelial-mesenchymal features and behaviors.
    J Cancer Res Clin Oncol. 2017 Apr 20. doi: 10.1007/s00432-017-2417.
    PubMed     Text format     Abstract available


    March 2017
  4. PAN L, Liang W, Fu M, Huang ZH, et al
    Exosomes-mediated transfer of long noncoding RNA ZFAS1 promotes gastric cancer progression.
    J Cancer Res Clin Oncol. 2017 Mar 11. doi: 10.1007/s00432-017-2361.
    PubMed     Text format     Abstract available


  5. LORDICK F, Al-Batran SE, Dietel M, Gaiser T, et al
    HER2 testing in gastric cancer: results of a German expert meeting.
    J Cancer Res Clin Oncol. 2017 Mar 11. doi: 10.1007/s00432-017-2374.
    PubMed     Text format     Abstract available


    February 2017
  6. ZHOU ZH, Ji CD, Zhu J, Xiao HL, et al
    The prognostic value and pathobiological significance of Glasgow microenvironment score in gastric cancer.
    J Cancer Res Clin Oncol. 2017 Feb 8. doi: 10.1007/s00432-017-2346.
    PubMed     Text format     Abstract available


    January 2017
  7. LI Y, Wang C, Xu M, Kong C, et al
    Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer.
    J Cancer Res Clin Oncol. 2017 Jan 20. doi: 10.1007/s00432-016-2330.
    PubMed     Text format     Abstract available


    December 2016
  8. HOU JY, Wang YG, Ma SJ, Yang BY, et al
    Identification of a prognostic 5-Gene expression signature for gastric cancer.
    J Cancer Res Clin Oncol. 2016 Dec 29. doi: 10.1007/s00432-016-2324.
    PubMed     Text format     Abstract available


  9. KNEISSL J, Hartmann A, Pfarr N, Erlmeier F, et al
    Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  10. OZE I, Shimada S, Nagasaki H, Akiyama Y, et al
    Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    November 2016
  11. STOLLBERG S, Kammerer D, Neubauer E, Schulz S, et al
    Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.
    J Cancer Res Clin Oncol. 2016;142:2239-47.
    PubMed     Text format     Abstract available


    October 2016
  12. CHEN HD, Zhou J, Wen F, Zhang PF, et al
    Cost-effectiveness analysis of apatinib treatment for chemotherapy-refractory advanced gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  13. DING WJ, Zhou M, Chen MM, Qu CY, et al
    HOXB8 promotes tumor metastasis and the epithelial-mesenchymal transition via ZEB2 targets in gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  14. LIU KT, Wan JF, Yu GH, Bei YP, et al
    The recommended treatment strategy for locally advanced gastric cancer in elderly patients aged 75 years and older: a Surveillance, Epidemiology, and End Results database analysis.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  15. YANG Y, Wang G, He J, Wu F, et al
    Robotic gastrectomy versus open gastrectomy in the treatment of gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  16. REN C, Chen H, Han C, Fu D, et al
    High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    August 2016
  17. CHEN WM, Wu CS, Liu JL, Yeh CM, et al
    Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  18. HUANG DD, Chen XX, Chen XY, Wang SL, et al
    Sarcopenia predicts 1-year mortality in elderly patients undergoing curative gastrectomy for gastric cancer: a prospective study.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  19. LI P, Sun D, Li X, He Y, et al
    Elevated expression of Nodal and YAP1 is associated with poor prognosis of gastric adenocarcinoma.
    J Cancer Res Clin Oncol. 2016;142:1765-73.
    PubMed     Text format     Abstract available


    June 2016
  20. TAKAHASHI N, Iwasa S, Sasaki Y, Shoji H, et al
    Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  21. SUN W, Yang Y, Xu C, Xie Y, et al
    Roles of long noncoding RNAs in gastric cancer and their clinical applications.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  22. POLOM K, Marrelli D, Pascale V, Roviello G, et al
    High-risk and low-risk gastric cancer areas in Italy and its association with microsatellite instability.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  23. FU JW, Kong Y, Sun X
    Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  24. KIM ST, Ahn S, Lee J, Lee SJ, et al
    Value of FGFR2 expression for advanced gastric cancer patients receiving pazopanib plus CapeOX (capecitabine and oxaliplatin).
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  25. CHEN Y, Huang Y, Zhu L, Chen M, et al
    SOX2 inhibits metastasis in gastric cancer.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


  26. MA Z, Ma Y, Xia Q, Li Y, et al
    MicroRNA-155 expression inversely correlates with pathologic stage of gastric cancer and it inhibits gastric cancer cell growth by targeting cyclin D1.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  27. ZHENG N, Xiao XM, Dong KR, Chen L, et al
    Primary gastric tumors in infants and children: 15 cases of 20-year report.
    J Cancer Res Clin Oncol. 2016.
    PubMed     Text format     Abstract available


    November 2015
  28. LEE KW, Lee JH, Kim JW, Kim JW, et al
    Population-based outcomes research on treatment patterns and impact of chemotherapy in older patients with metastatic gastric cancer.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  29. ZHAO JH, Sun JX, Song YX, Chen XW, et al
    A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


    October 2015
  30. PARK HL, Yoo IeR, O JH, Han EJ, et al
    F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.
    J Cancer Res Clin Oncol. 2015;141:1871-8.
    PubMed     Text format     Abstract available


  31. OUYANG H, Xu J, Zhu Z, Long T, et al
    Rapid discrimination of malignant lesions from normal gastric tissues utilizing Raman spectroscopy system: a meta-analysis.
    J Cancer Res Clin Oncol. 2015;141:1835-44.
    PubMed     Text format     Abstract available


    September 2015
  32. NUMATA K, Oshima T, Sakamaki K, Yoshihara K, et al
    Clinical significance of IGF1R gene expression in patients with Stage II/III gastric cancer who receive curative surgery and adjuvant chemotherapy with S-1.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  33. CHEN JJ, Hong G, Gao LJ, Liu TJ, et al
    In vitro and in vivo antitumor activity of a novel porphyrin-based photosensitizer for photodynamic therapy.
    J Cancer Res Clin Oncol. 2015;141:1553-61.
    PubMed     Text format     Abstract available


    August 2015
  34. ZHOU D, Jiang X, Ding W, Zheng L, et al
    Retraction Note to: siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format    


  35. YU S, Li G, Wang Z, Wang Z, et al
    The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
    J Cancer Res Clin Oncol. 2015.
    PubMed     Text format     Abstract available


  36. KOOPMAN T, Smits MM, Louwen M, Hage M, et al
    HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison.
    J Cancer Res Clin Oncol. 2015;141:1343-51.
    PubMed     Text format     Abstract available


    July 2015
  37. PENG WJ, Jia XJ, Wei BG, Yang LS, et al
    Stomach cancer mortality among workers exposed to asbestos: a meta-analysis.
    J Cancer Res Clin Oncol. 2015;141:1141-9.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: